Vitiligo is caused by the immune system attacking and destroying melanocytes, the cells that produce skin pigment. It affects roughly 0.5 to 2% of the global population, and while no single factor is responsible, the process involves a combination of genetic susceptibility, cellular stress, and environmental triggers that together push the immune system into overdrive against the skin’s own pigment-producing cells.
The Immune System Turns on Melanocytes
At its core, vitiligo is an autoimmune condition. Your immune system, which normally targets viruses and bacteria, mistakenly identifies melanocytes as threats and sends specialized killer cells to destroy them. The final blow comes from CD8+ cytotoxic T cells, a type of white blood cell that directly attacks and kills melanocytes through multiple pathways. These cells punch holes in melanocyte membranes using proteins called perforin and granzymes, and they also trigger a self-destruct signal within the melanocytes themselves.
What makes this process self-reinforcing is a signaling molecule called IFN-gamma, released by the attacking T cells. IFN-gamma does two things simultaneously: it recruits even more killer T cells to the area, and it creates a localized toxic environment that is lethal to melanocytes while leaving surrounding skin cells unharmed. This precision targeting explains why vitiligo produces sharply defined white patches rather than a general fading of skin color.
Once this immune response establishes itself in a patch of skin, memory T cells take up residence there. These sentinel cells remain even after treatment restores color, which is why vitiligo patches often reappear in the same location. When these resident memory cells detect melanocyte proteins, they release IFN-gamma and restart the cycle of destruction.
Genetics Load the Gun
Vitiligo runs in families, though it doesn’t follow a simple inheritance pattern. Rather than a single “vitiligo gene,” dozens of genetic variants each contribute a small increase in risk. Most of these genes control how the immune system functions. PTPN22 influences how T cells respond to signals. CTLA4 normally acts as a brake on T cell activity. FOXP3 controls regulatory T cells, the immune cells responsible for preventing autoimmune attacks. When variants in these genes weaken the body’s ability to keep the immune system in check, the risk of vitiligo rises.
Other susceptibility genes operate outside the immune system entirely. NLRP1 regulates innate immune responses in the skin and acts as an early warning system for infection. XBP1 helps cells cope with internal stress and also activates parts of the immune system. GZMB encodes one of the very molecules that killer T cells use to destroy melanocytes. Having risk variants in several of these genes at once creates a biological environment where a relatively minor trigger can set off a disproportionate immune response against melanocytes.
Oxidative Stress Sets the Stage
Before the immune system ever gets involved, melanocytes in vitiligo-prone skin are already under strain. Researchers have found that the outer layer of skin in vitiligo patients accumulates hydrogen peroxide at concentrations roughly a thousand times higher than normal. This buildup of reactive oxygen species damages melanocytes from the inside, impairing the antioxidant systems that would normally neutralize these harmful molecules.
Vitiligo melanocytes appear inherently more vulnerable to this kind of damage. Compared to normal melanocytes, they have lower levels of protective antioxidant enzymes, making them more sensitive to oxidative injury. This creates a vicious cycle: stressed melanocytes release fragments of themselves that the immune system recognizes as foreign, which triggers the autoimmune attack described above. In this way, oxidative stress doesn’t just weaken melanocytes directly. It also sounds the alarm that draws the immune system’s attention to them.
Environmental Triggers That Activate Vitiligo
For most people with vitiligo, the condition doesn’t appear out of nowhere. Something in the environment pushes a genetically susceptible person over the threshold. Known triggers include severe sunburn, emotional or psychological stress, hormonal changes, and exposure to certain industrial chemicals. Phenol-based compounds are particularly well documented. A chemical called 4-tertiary butyl phenol, found in some adhesives, rubber products, and industrial settings, causes melanocyte death and has been identified as a direct cause of occupational vitiligo. Monobenzyl ether of hydroquinone, once used in skin-lightening products, triggers a different but equally lethal pathway in melanocytes.
Physical trauma to the skin is another important trigger, through a process called the Koebner phenomenon. When skin is injured by a cut, burn, or friction, new vitiligo patches can develop at the injury site. In one study of 418 vitiligo patients, 62% showed this response. It was especially common in non-segmental vitiligo, where about 76% of patients developed new patches at sites of skin trauma. This is why some people first notice vitiligo appearing along bra straps, belt lines, or areas of repeated friction.
The Nerve Connection
A subset of vitiligo, called segmental vitiligo, follows the distribution of a single nerve and affects only one side of the body. This pattern has long suggested that nerve signaling plays a role. Neuropeptides and neurotransmitters released by skin nerve endings, including neuropeptide Y and dopamine, can influence melanocyte survival. These chemical signals connect cutaneous nerves to the immune system through a two-way network, meaning that nerve activity in the skin can locally amplify or trigger the inflammatory cascade that destroys melanocytes.
This neural pathway doesn’t replace the immune explanation. Instead, it feeds into it. Nerve-released chemicals can influence regulatory T cells and activate the same signaling axis that recruits killer T cells to the skin. For people with segmental vitiligo, nerve dysfunction may be the initial spark, but the melanocyte destruction still ultimately depends on immune activation.
Why Vitiligo Clusters With Other Conditions
Because vitiligo stems from a broadly dysregulated immune system rather than a problem specific to the skin, it frequently appears alongside other autoimmune conditions. A 10-year study of 3,280 patients found that roughly 23% of people with vitiligo had at least one other autoimmune disorder, including thyroid disease, rheumatoid arthritis, inflammatory bowel disease, lupus, or type 1 diabetes.
Thyroid disease is the most common companion. A meta-analysis covering over 78,000 vitiligo patients found that 15.7% had thyroid disease, a rate significantly higher than in the general population. About 17% tested positive for thyroid antibodies, indicating their immune system was actively attacking thyroid tissue even when no thyroid symptoms were present. This overlap reinforces that vitiligo is not simply a cosmetic condition. It reflects a systemic tendency toward autoimmunity that can affect multiple organs.